CEO SUMMARY: Stock prices for laboratory and pathology companies have skyrocketed since the new decade of the 2000s dawned on January 1. Is investor optimism warranted by the opportunities ahead in diagnostic testing? Or will history repeat itself if the continuing evolution of American healthcare proves as financially unhealthy to independent lab and pathology firms […]
Is it Early-90s “Deja Vu” For Today’s Lab Industry?
As the decade of the 1990s opened, it was a roaring stock market for lab companies
- By Robert Michel
- > From the Volume VII No. 14 - October 2, 2000 Issue
- Tags: blood brothers, cap, care contracts, clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, commercial laboratories, compliance program, compliance programs, dark report, diagnostic testing, impac, lab executive, lab industry, lab test, lab testing, laboratories, laboratory company, laboratory compliance, laboratory industry, managed care, managed care contract, managed care contracts, medical lab, medical laboratories, Medicare, pathologists, pathology companies, specialty lab, specialty laboratories, the clinical laboratory, the dark report, the laboratory
